- Home
- ETW vs STAA Comparison
ETW vs STAA Comparison
Compare ETW & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
ETW
Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Current Price
Company Overview
Basic Information| Metric | ETW | STAA |
|---|---|---|
| Founded | N/A | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 867.9M |
| IPO Year | 2005 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ETW | STAA |
|---|---|---|
| Price | $9.00 | $18.62 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $21.61 |
| AVG Volume (30 Days) | 337.3K | ★ 1.2M |
| Earning Date | 01-01-0001 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | N/A | $33.83 |
| Revenue Next Year | N/A | $8.16 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.93 | $14.69 |
| 52 Week High | $9.60 | $30.81 |
Technical Indicators
Market Signals| Indicator | ETW | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 37.24 | 50.84 |
| Support Level | $8.87 | $17.13 |
| Resistance Level | $9.13 | $20.01 |
| Average True Range (ATR) | 0.10 | 0.94 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 10.62 | 50.77 |
Price Performance
Historical ComparisonAbout ETW Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.